Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?
Year: 2015
Type: article
Abstract: Vaccination can place selective pressures on viral populations, leading to changes in the distribution of strains as viruses evolve to escape immunity from the vaccine. Vaccine-driven strain replacement is a major concern after nationwide rotavirus vaccine introductions. However, the distribution of the predominant rotavirus genotypes varies from year to year in the absence of vaccination, making it difficult to determine what changes can be attributed to the vaccines. To gain insight in the underlying dynamics driving changes in the rotavirus population, we fitted a hierarchy of mathematical models to national and local genotype-specific hospitalization data from Belgium, where large-scale vaccination was introduced in 2006. We estimated that natural- and vaccine-derived immunity was strongest against completely homotypic strains and weakest against fully heterotypic strains, with an intermediate immunity amongst partially heterotypic strains. The predominance of G2P[4] infections in Belgium after vaccine introduction can be explained by a combination of natural genotype fluctuations and weaker natural and vaccine-induced immunity against infection with strains heterotypic to the vaccine, in the absence of significant variation in strain-specific vaccine effectiveness against disease. However, the incidence of rotavirus gastroenteritis is predicted to remain low despite vaccine-driven changes in the distribution of genotypes.
Source: Scientific Reports
DOI: 10.1038/srep18585
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funders: U.S. Department of Homeland Security, Bill and Melinda Gates Foundation, Yale University, Fonds Wetenschappelijk Onderzoek, Vlaamse regering, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1794538721, Yale Biomedical Supercomputer, G2348540762, G292646880, G5134620430, High Performance Computing Instrumentation for Yale University Biomedical HPC Cen, G6865122141, Yale University Clinical and Translational Science Award Program, Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countries
OpenAlex ID: W2261330698
